PET/CT imaging 2 h after injection of [ 18 F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h.
Erland HvittfeldtUlrika BitzénDavid MinarikJenny OddstigBerit OlssonElin TrägårdhPublished in: European journal of hybrid imaging (2023)
F]PSMA-1007 leads to more suspected metastases found than after 1 h, with higher staging in some patients and possible effect on patient treatment.
Keyphrases
- pet ct
- prostate cancer
- high resolution
- end stage renal disease
- positron emission tomography
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- case report
- lymph node
- radical prostatectomy
- pulmonary embolism
- combination therapy
- patient reported outcomes
- computed tomography
- pet imaging
- ultrasound guided
- fluorescence imaging